Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours

Area of Science:

• Oncology
• Molecular Biology
• Signal Transduction

Background:

• Fyn is a nonreceptor tyrosine kinase and a member of the Src family of kinases (SFKs).
• Fyn plays critical roles in cellular processes like motility, proliferation, and death, influencing cancer development.
• SFKs, including Fyn, are frequently overexpressed or hyperactive in tumors, promoting oncogenesis.

Purpose of the Study:

• To review recent findings on the function of Fyn in tumor development and progression.
• To highlight the specific role of Fyn in gliomas.
• To provide a foundation for targeted Fyn inhibition therapies.

Main Methods:

• Literature review of recent studies on Fyn kinase.
• Analysis of Fyn's role in various cancer types, with a focus on gliomas.
• Examination of Fyn's involvement in tumorigenesis, cancer development, and therapeutic resistance.

Main Results:

• Fyn kinase activity is implicated in the development and progression of multiple cancer types.
• Fyn plays a significant role in glioma development and progression.
• Inhibition of Fyn kinase has the potential to improve patient outcomes and survival rates.

Conclusions:

• Fyn kinase is a viable therapeutic target for various cancers, particularly gliomas.
• Understanding Fyn's function in cancer is crucial for developing novel targeted therapies.
• Targeting Fyn can enhance the efficacy of anticancer treatments and improve cancer management.